- ￥861 - 5355
- MedChemExpress(MCE)
- 美国
- HY-114017
- 2025年12月05日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
Powder: -20°C, 3 years; 4°C, 2 years.In solvent: -80°C, 6 months; -20°C, 1 month.
- 英文名：
SAF312; Vanilloid receptor antagonist 1
- 库存：
货期：1-2天
- 供应商：
MedChemExpress LLC
- CAS号：
871814-52-7
- 规格：
10 mM * 1 mL/1 mg/5 mg/10 mg/25 mg
| 规格： | 10 mM * 1 mL | 产品价格： | ￥1411.0 |
|---|---|---|---|
| 规格： | 1 mg | 产品价格： | ￥861.0 |
| 规格： | 5 mg | 产品价格： | ￥2100.0 |
| 规格： | 10 mg | 产品价格： | ￥3150.0 |
| 规格： | 25 mg | 产品价格： | ￥5355.0 |
MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。
Vanilloid receptor antagonist 1
CAS No. : 871814-52-7
MCE 国际站：Vanilloid receptor antagonist 1
产品活性：Vanilloid receptor antagonist 1 是一种有效的香草酸受体 (TRPV1) 拮抗剂，详细信息请参考专利 US8349852B2 中的compound B8。
研究领域：Membrane Transporter/Ion Channel | Neuronal Signaling
作用靶点：TRP Channel
相关产品：Bioactive Compound Library Plus | Immunology/Inflammation Compound Library | Membrane Transporter/Ion Channel Compound Library | Neuronal Signaling Compound Library | Mechanoreceptors Compound Library | Pain-Related Compound Library | Membrane Protein-targeted Compound Library | Membrane Receptor-targeted Compound Library | Ion Channel Compound Library | Rosiglitazone | Capsaicin | GsMTx4 | EIPA | Probenecid | Diphenyleneiodonium chloride | 2-Aminoethyl diphenylborinate | Amiloride hydrochloride | GSK1016790A | Capsazepine | HC-067047 | HC-030031 | ML-SA1 | GSK2193874 | Adenosine 5′-diphosphoribose sodium | AMG9810 | GSK205 | SKF-96365 hydrochloride | (-)-Menthol | Caffeic acid | ML-SI1 | BI-749327 | GSK2798745 | Pregnenolone | ML-SA5 | N-(p-amylcinnamoyl) Anthranilic Acid | A-967079 | MK6-83 | Pico145
热门产品线：重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Chemokine Receptor Antagonist Development
This chapter describes assays that focus on the characterization of compounds identified in high-�throughput screening campaigns, and the subsequent medicinal chemistry programs. They cover methods to determine potency
Developing a Photoreactive Antagonist
approach for developing small molecules that, upon irradiation with light, may be used to rapidly inactivate targeted proteins expressed on the surfaces of cells. Highlighted is ANQX, a photoreactive AMPA receptor antagonist developed to irreversibly
Prasugrel: A Novel Platelet ADP P2Y12 Receptor Antagonist
than clopidogrel without an unacceptable increase in hemorrhagic or other side effects. Prasugrel (CS-747; LY-640315), a novel third-generation oral thienopyridine, is a specific, irreversible antagonist of the platelet ADP P2Y12 receptor. Pre-clinical and early
技术资料暂无技术资料 索取技术资料
